osteoporosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: With WHO about osteopenia and osteoporosis diagnosis standards; Patients with postmenopausal osteoporosis; No obvious heart, liver, kidney, lung dysfunction; Voluntary as test subjects, signed informed consent form and can be received the experimental drug dosage form.
Exclusion criteria
Exclusion criteria: The treatment group patients do not accord with standard of osteoporosis diagnosis; Have all sorts of secondary osteoporosis caused by endocrine disease, such as diabetes, thyroid and parathyroid disease, Gushing syndrome, etc.; Chronic kidney disease, chronic gastrointestinal disease, joint disease, blood system diseases, and other serious illness interference bone metabolism; Serious violence caused by fracture. Pathological fractures caused by tumor metastasis or bone tumor; Taken within 6 months of bone metabolism and anti osteoporosis drugs, including: parathyroid hormone, sex hormone, diuretics, glucocorticoid, calcitonin, calcium, vitamin D analogue, two phosphate, fluoride, etc; Patients with cardiovascular disease, high cholesterol and lipid-lowering drugs patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TGF-ß1?BMP-2?Wnt\ß-catien?PINP?ß-Crosslaps?N-MID; | — |
Countries
china